This course presents a focused look at the FDA’s rule classifying the vaginal hydrogel packing system as a class II medical device under 21 CFR 892.5735. Learn the essential compliance steps, special controls, and regulatory submissions required to lawfully market and distribute these devices. Detailed guidance on clinical and non-clinical performance, labeling, biocompatibility, and risk mitigation ensures you are prepared to meet FDA standards and maintain access to the U.S. market.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying the vaginal hydrogel packing system as a class II device.
* Identify the special controls and general controls applicable to this device type.
* Recognize the key compliance requirements for marketing and distributing these devices.
* Implement actionable steps to meet FDA requirements and avoid regulatory penalties.
